Phase I/II Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer Following Progression on Prior BRAF+EGFR Targeted Therapies.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined